As per MRFR analysis, the Human Milk Oligosaccharides Market Size was estimated at 0.51 (USD Billion) in 2023.The Human Milk Oligosaccharides Market is expected to grow from 0.58 (USD Billion) in 2024 to 2.5 (USD Billion) by 2035. The Human Milk Oligosaccharides Market CAGR (growth rate) is expected to be around 14.21% during the forecast period (2025 - 2035)
Key Human Milk Oligosaccharides Market Trends Highlighted
The Human Milk Oligosaccharides Market is experiencing significant growth influenced by various market drivers. An increasing awareness of the health benefits associated with breastfeeding has led parents to seek products enriched with human milk oligosaccharides (HMOs), which are known to support infant health. This shift in consumer preference is driven by a greater understanding of the role of HMOs in enhancing gut health, promoting immunity, and supporting brain development. Additionally, the rise in the number of working mothers has led to a demand for HMO-based supplements that mimic the effects of human milk, further propelling market growth.
There are chances to make new infant formulas and functional foods that include HMOs. As more research shows how these oligosaccharides can be good for your health, companies can make more products for both babies and adults. Companies could also work with research institutions to find new ways to use HMOs to improve health, which would be a great opportunity for them to come up with new ideas. Recent trends show that people are more interested in clean-label products, which means they want to know where the ingredients come from and how they are made.
The market is witnessing a rise in demand for organic and ethically sourced HMOs, reflecting a broader trend of sustainability and responsible consumption. Enhanced distribution channels, particularly online, are gaining traction, allowing easier access to HMO-based products. As awareness grows and consumer preferences change, the market is evolving to meet new demands, making it a dynamic space for growth and innovation.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Human Milk Oligosaccharides Market Drivers
Increase in Infant Formula Demand
The demand for infant formula is on the rise ly, driven by factors such as an increasing number of working mothers and rising awareness about nutrition. According to a recent survey by the World Health Organization, nearly 40% of infants worldwide are currently fed formula in addition to breastfeeding. This highlights a growing market for products like human milk oligosaccharides, which are finding their way into infant formulas as a means to mimic the health benefits of breast milk.
Fortune 500 companies in the food and beverage sector, such as Nestlé and Danone, are increasingly investing in Research and Development to enhance their formula offerings. With the Human Milk Oligosaccharides Market expected to benefit from these innovations, this demand surge indicates a favorable growth trajectory for human milk oligosaccharides in infant nutrition.
Rising Awareness of Gut Health
awareness regarding gut health has significantly increased over recent years, with various public health campaigns highlighting the role of prebiotics in maintaining a healthy digestive system. The International Scientific Association for Probiotics and Prebiotics reports that approximately 70% of consumers are likely to choose products that promote gut health. Human milk oligosaccharides serve as prebiotics, thus making them a popular choice among health-conscious consumers.
Organizations like the Food and Drug Administration are recognizing the importance of gut health, which drives demand for functional foods. Consequently, as awareness spreads, the Human Milk Oligosaccharides Market is set to expand, with market players capitalizing on this trend to promote their products.
Growing Investment in Biotechnology
With advancements in biotechnology, the ability to synthesize human milk oligosaccharides has remarkably improved, resulting in higher product availability and cost efficiency. The Biotechnology Innovation Organization reports that the biotechnology market is projected to grow at a rate of 15% per year, largely fueled by innovations in food biotechnology and nutritional science. This surge is likely to enhance the feasibility of incorporating human milk oligosaccharides into various formulations, including dietary supplements.
Multinational corporations like BASF are actively pursuing biotechnology patents to optimize oligosaccharides production, paving the way for growth in the Human Milk Oligosaccharides Market.
Human Milk Oligosaccharides Market Application Insights
The Application segment of the Human Milk Oligosaccharides Market demonstrates substantial growth potential and represents a significant portion of the overall market dynamics. In 2024, the market is set to be valued at 0.58 billion USD, with various applications playing critical roles in its expansion. Among the different applications, the Infant Formula segment holds a majority share, valued at 0.3 billion USD in 2024 and projected to grow to 1.3 billion USD by 2035. This segment is vital as Human Milk Oligosaccharides are recognized for their benefits in infant nutrition, promoting healthy gut microbiota and immune system development, thus making it an attractive choice for parents seeking alternatives to traditional formulas.
Following this, the Functional Foods application is valued at 0.15 billion USD in 2024, with expectations to rise to 0.6 billion USD by 2035. Functional foods incorporating Human Milk Oligosaccharides not only appeal to health-conscious consumers looking for added nutritional benefits but also tap into a growing trend towards lifestyle and dietary improvements among all age groups. Lastly, the Dietary Supplements segment, valued at 0.13 billion USD in 2024 and forecasted to reach 0.6 billion USD by 2035, complements the growing awareness of gut health and overall wellness, positioning itself as a key player for consumers interested in enhancing their daily nutrient intake.
Overall, the Human Milk Oligosaccharides Market segmentation reflects a shift in consumer preferences towards health-oriented products, driving innovation and presence across various nutritional products ly. The projected growth rates, coupled with increasing investment in research and development, signify a robust trajectory fueled by rising health awareness and a shrinking gap between consumer expectations for nutrition and available products.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Human Milk Oligosaccharides Market Source Insights
The Source segment of the Human Milk Oligosaccharides Market encompasses key categories, including Human Milk, Synthetic Production, and Animal Milk, showcasing a robust structure contributing to the overall growth. In 2024, the market is set to reach a valuation of 0.58 billion USD, illustrating a marked interest in the diverse applications of human milk oligosaccharides. Human Milk remains a critical source for oligosaccharides that naturally support infant health, while Synthetic Production is gaining traction due to advancements in technology, enabling the creation of alternatives that mimic natural profiles.
Animal Milk is also significant as it offers a broader appeal for nutritional products aimed at fostering gut health in various consumer segments. The increasing awareness of the health benefits associated with these oligosaccharides drives market growth, as many studies link them to improved immune response and digestive health. The demand for functional foods and infant formulas further propels the industry, as consumers seek products that cater to health and wellness. Thus, the segmentation of this market highlights the diverse methodologies in sourcing human milk oligosaccharides, each playing a vital role in addressing the needs of a health-conscious population.
Human Milk Oligosaccharides Market Form Insights
The Human Milk Oligosaccharides Market is projected to be valued at 0.58 USD billion by 2024, with a strong focus on the Form segment, which consists of various formats such as Powder, Liquid, and Capsules. This segment plays a vital role in the overall market dynamics, particularly due to its application in infant nutrition and probiotics, which are increasingly gaining traction ly. The Powder form is prevalent due to its convenience and longer shelf life, making it a preferred choice for manufacturers. The Liquid variant is cherished for its ease of use and rapid absorption, catering to specific consumer preferences.
Meanwhile, the Capsules format provides a user-friendly option for adults seeking health benefits, thus broadening the customer base. The increasing recognition of the health benefits associated with Human Milk Oligosaccharides fosters market growth, supported by trends such as the rising birth rate and growing awareness of infant health. However, challenges include regulatory hurdles and the need for extensive Research and Development to ensure product safety and efficacy. Overall, the Form segment poses significant opportunities for market expansion and innovation in diverse applications across various demographics within the Human Milk Oligosaccharides Market.
Human Milk Oligosaccharides Market End Use Insights
The Human Milk Oligosaccharides Market is witnessing significant expansion, particularly in its End Use segment, which encompasses Healthcare, Food and Beverages, and Nutraceuticals. In 2024, the market is expected to reach a valuation of 0.58 USD billion, showcasing the growing recognition of human milk oligosaccharides for their health benefits. The Healthcare sector plays a critical role, as these compounds are known to support immune function and gut health in infants, thereby driving growth in products aimed at pediatric nutrition. Additionally, the Food and Beverages segment benefits from rising consumer demand for functional foods that offer additional health advantages, with human milk oligosaccharides being highlighted for their prebiotic properties.
In the Nutraceuticals category, the increasing popularity of dietary supplements and fortified foods enhances the relevance of human milk oligosaccharides, reflecting a trend towards health-conscious consumption among consumers. Overall, these segments are integral to the Human Milk Oligosaccharides Market revenue growth, as they present significant opportunities in addressing health-related concerns in the population.
Human Milk Oligosaccharides Market Regional Insights
The Human Milk Oligosaccharides Market exhibits noteworthy dynamics across the Regional segment, with anticipated values highlighting significant growth. In 2024, the market for North America is valued at 0.2 USD Billion, reflecting its position as a leading region, which is likely to rise to 0.85 USD billion by 2035, exhibiting a majority holding in market size. Europe follows closely, valued at 0.15 USD billion in 2024 and projected to reach 0.65 USD billion by 2035, showcasing its important role in the overall market. The South American market, though smaller, is expected to grow from 0.05 USD billion in 2024 to 0.2 USD billion by 2035, revealing opportunities for future expansion.
The Asia Pacific region is also significant, with a valuation of 0.13 USD billion in 2024 and a projected increase to 0.54 USD billion by 2035, driven by rising consumer awareness and demand for infant nutrition products. Lastly, the Middle East and Africa market, currently valued at 0.05 USD billion in 2024, is projected to grow to 0.26 USD billion by 2035, signaling emerging potential in this region. Overall, the Human Milk Oligosaccharides Market statistics reveal robust prospects and diverse growth opportunities across all regions, underscoring the vital role of human milk oligosaccharides in infant health and nutrition.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Human Milk Oligosaccharides Market Key Players and Competitive Insights
The Human Milk Oligosaccharides Market is witnessing a dynamic landscape characterized by a surge in demand for functional ingredients that promote infant health and development. Human milk oligosaccharides (HMOs) are gaining recognition due to their prebiotic properties and ability to support gut health, immunity, and overall growth in infants. As more stakeholders recognize the significance of these complex carbohydrates, the competitive environment is expected to intensify. Companies are strategizing on product innovations, enhancing distribution networks, and strengthening their market presence to capitalize on the evolving consumer preferences toward natural and holistic feeding options. The growing awareness regarding the nutritional benefits of breast milk and the increasing prevalence of lactose intolerance are further driving the demand for HMOs ly, leading to a robust competitive scenario that encourages participants to push the boundaries of product development and market reach.
Medolac Laboratories has established itself as a crucial player within the Human Milk Oligosaccharides Market, emphasizing its commitment to providing high-quality HMO-derived products. The company leverages advanced scientific research to enhance its product portfolio, focusing on the nutritional and functional aspects of HMOs in infant formulas and other applications. Medolac Laboratories stands out for its robust manufacturing capabilities and investment in R&D, enabling it to meet the rising demand efficiently. Its market presence is bolstered by strategic partnerships and collaborations within the industry, allowing access to innovative technologies and expansion opportunities. Through a focus on quality assurance and regulatory compliance, Medolac Laboratories enhances its credibility among health care professionals and consumers, solidifying its competitive edge in the arena.
Prolacta Bioscience has positioned itself as a leader in the Human Milk Oligosaccharides Market by focusing on the development and commercialization of premium HMO products. The company is well-known for its revolutionary infant nutritional solutions that incorporate HMOs to support the health of premature infants. Prolacta Bioscience benefits from a strong R&D framework, enabling it to innovate continuously and respond to emerging market needs. Its commitment to clinical research establishes the efficacy of its offerings, making it a preferred choice among hospitals and healthcare providers. Prolacta's strategic initiatives often involve collaborations and partnerships that enhance its product lineup and expand its reach into new markets. Furthermore, any recent mergers and acquisitions have likely fortified its market presence, ensuring that Prolacta remains a key player in shaping the future of nutritional solutions for infants, particularly in the context of HMOs.
Key Companies in the Human Milk Oligosaccharides Market Include
Human Milk Oligosaccharides Market Developments
The Human Milk Oligosaccharides Market has seen significant developments recently, with Medolac Laboratories, Prolacta Bioscience, and Ferring Pharmaceuticals making strides in product offerings and innovations. In August 2023, FrieslandCampina launched new line extensions aimed at enhancing infant nutrition, reflecting a growing interest in the applications of human milk oligosaccharides. Abbott Laboratories and DuPont have been active in Research and Development to fortify their portfolios in this sector. Notably, there were reports of a strategic collaboration between Ginkgo BioWorks and Synlogic in early September 2023, focusing on developing biotechnologies that utilize oligosaccharides for health benefits.
The market valuation of these companies is anticipated to rise as investments in research surge for developing functional ingredients in infant formulas, propelled by increasing awareness of the benefits of human milk oligosaccharides. The demand for these products is significantly impacting the market landscape, with companies like Glycom A/S and Nestlé also enhancing their capacities. Over the past two years, regulatory initiatives have propelled the recognition of oligosaccharides, which contribute to immune health and digestive wellness, fostering a thriving market environment.
Human Milk Oligosaccharides Market Segmentation Insights
Human Milk Oligosaccharides Market Application Outlook
Human Milk Oligosaccharides Market Source Outlook
Human Milk Oligosaccharides Market Form Outlook
Human Milk Oligosaccharides Market End Use Outlook
Human Milk Oligosaccharides Market Regional Outlook
| Report Attribute/Metric | Details |
| Market Size 2023 | 0.51 (USD Billion) |
| Market Size 2024 | 0.58 (USD Billion) |
| Market Size 2035 | 2.5 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 14.21% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medolac Laboratories, Prolacta Bioscience, Ferring Pharmaceuticals, Lifescience Dynamics, Synlogic, TExGEM, Nestlé, FrieslandCampina, Ginkgo BioWorks, Glycom A/S, Abbott Laboratories, DuPont |
| Segments Covered | Application, Source, Form, End Use, Regional |
| Key Market Opportunities | Rising demand for infant nutrition, Increasing investment in research and development, Growing awareness of gut health, Expanding applications in functional foods, Emerging markets and demographics |
| Key Market Dynamics | Rising demand for infant formula, increasing health awareness, advancements in oligosaccharide extraction, growing research and development, expanding retail channels |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Human Milk Oligosaccharides Market Highlights:
Frequently Asked Questions (FAQ):
The Human Milk Oligosaccharides Market is expected to be valued at 0.58 USD billion in 2024.
By 2035, the Human Milk Oligosaccharides Market is projected to reach a value of 2.5 USD billion.
The expected CAGR for the Human Milk Oligosaccharides Market from 2025 to 2035 is 14.21%.
The Infant Formula application segment is anticipated to have the largest market size of 1.3 USD Billion in 2035.
The Functional Foods application segment is expected to be valued at 0.15 USD billion in 2024 and 0.6 USD billion in 2035.
North America is expected to dominate the market with a value of 0.85 USD billion in 2035.
The Asia Pacific region is valued at 0.13 USD billion in 2024 and is projected to reach 0.54 USD billion by 2035.
Key players in the Human Milk Oligosaccharides Market include Medolac Laboratories, Prolacta Bioscience, and Nestlé.
The Dietary Supplements segment is projected to grow from 0.13 USD billion in 2024 to 0.6 USD Billion in 2035, indicating substantial growth opportunities.
The South America region is estimated to have a market value of 0.2 USD billion by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager - Research High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. by implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in packaging, construction, and equipment domains. she handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
